Dr. Howard Benn, MD

NPI: 1841364965
Total Payments
$29,880
2024 Payments
$2,405
Companies
71
Transactions
854
Medicare Patients
1,530
Medicare Billing
$354,890

Payment Breakdown by Category

Food & Beverage$14,160 (47.4%)
Consulting$10,950 (36.6%)
Other$3,150 (10.5%)
Education$1,620 (5.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,160 822 47.4%
Consulting Fee $10,950 8 36.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,150 1 10.5%
Education $1,620 23 5.4%

Top Paying Companies

Company Total Records Latest Year
INSYS Therapeutics Inc $7,930 12 $0 (2018)
E.R. Squibb & Sons, L.L.C. $3,396 72 $0 (2024)
Global Blood Therapeutics, Inc. $3,022 7 $0 (2022)
AstraZeneca Pharmaceuticals LP $1,624 80 $0 (2024)
PUMA BIOTECHNOLOGY, INC. $1,160 6 $0 (2024)
Amgen Inc. $1,083 45 $0 (2023)
Merck Sharp & Dohme LLC $978.06 70 $0 (2024)
Novartis Pharmaceuticals Corporation $927.88 61 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $876.60 53 $0 (2024)
Sirtex Medical Inc $782.83 33 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,405 123 AstraZeneca Pharmaceuticals LP ($366.84)
2023 $2,369 133 Celgene Corporation ($226.39)
2022 $4,323 147 E.R. Squibb & Sons, L.L.C. ($1,887)
2021 $5,997 110 Global Blood Therapeutics, Inc. ($2,979)
2020 $1,343 82 Amgen Inc. ($268.71)
2019 $2,712 95 Puma Biotechnology, Inc. ($1,101)
2018 $7,911 99 INSYS Therapeutics Inc ($6,581)
2017 $2,819 65 INSYS Therapeutics Inc ($1,348)

All Payment Transactions

854 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/19/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $16.42 General
Category: Oncology
12/17/2024 PUMA BIOTECHNOLOGY, INC. Food and Beverage In-kind items and services $15.30 General
12/10/2024 Janssen Biotech, Inc. CARVYKTI (Drug) Food and Beverage In-kind items and services $16.85 General
Category: Oncology
12/05/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $14.51 General
Category: Oncology
12/03/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $15.53 General
Category: Oncology
11/26/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $20.63 General
Category: Oncology
11/22/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $13.74 General
Category: ONCOLOGY
11/21/2024 Astellas Pharma US Inc Vyloy (Drug) Food and Beverage In-kind items and services $16.86 General
Category: Oncology
11/19/2024 Tempus AI, Inc Food and Beverage In-kind items and services $28.92 General
11/15/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $13.76 General
Category: ONCOLOGY
11/12/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $13.98 General
Category: Oncology
11/08/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $23.62 General
Category: Immunology
11/06/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $19.07 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
10/31/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $15.09 General
Category: ONCOLOGY
10/25/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $14.77 General
Category: HEMATOLOGY/ONCOLOGY
10/24/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $16.59 General
Category: HORMONE THERAPY
10/21/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.40 General
10/18/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $17.17 General
10/15/2024 Takeda Pharmaceuticals U.S.A., Inc. ICLUSIG (Drug) Food and Beverage In-kind items and services $14.50 General
Category: ONCOLOGY
10/12/2024 PFIZER INC. INLYTA (Drug), PADCEV Food and Beverage In-kind items and services $17.84 General
Category: ONCOLOGY
10/11/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.53 General
Category: Iron Deficiency Anemia
10/09/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $13.34 General
Category: Oncology
10/08/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $24.52 General
Category: Oncology
10/04/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $21.64 General
Category: ONCOLOGY
09/30/2024 Tempus AI, Inc XT CDX (Device) Food and Beverage In-kind items and services $30.35 General
Category: NONE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 453 999 $217,985 $92,647
2022 7 339 836 $187,940 $76,020
2021 9 406 1,051 $236,315 $97,401
2020 7 332 1,059 $254,730 $88,823
Total Patients
1,530
Total Services
3,945
Medicare Billing
$354,890
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 132 347 $83,280 $36,629 44.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 94 374 $59,840 $25,662 42.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 48 54 $24,030 $8,159 34.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 29 37 $12,025 $5,440 45.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 49 65 $10,725 $5,102 47.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 29 48 $11,040 $4,976 45.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 29 29 $10,585 $3,737 35.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 29 31 $3,100 $1,536 49.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 14 14 $3,360 $1,406 41.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 107 308 $73,920 $31,794 43.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 98 368 $58,530 $22,506 38.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 42 60 $19,500 $8,000 41.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 36 37 $16,465 $6,254 38.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 25 25 $9,125 $3,311 36.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 14 14 $6,440 $2,598 40.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 17 24 $3,960 $1,558 39.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 106 552 $88,320 $34,508 39.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 72 168 $54,600 $24,433 44.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 65 76 $33,820 $13,360 39.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 67 118 $28,320 $13,096 46.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 22 53 $12,190 $4,769 39.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 20 20 $7,300 $2,793 38.3%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 15 15 $6,900 $2,779 40.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 19 21 $3,465 $1,296 37.4%
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic Office 2021 20 28 $1,400 $366.52 26.2%

About Dr. Howard Benn, MD

Dr. Howard Benn, MD is a Specialist healthcare provider based in Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841364965.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Benn, MD has received a total of $29,880 in payments from pharmaceutical and medical device companies, with $2,405 received in 2024. These payments were reported across 854 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($14,160).

As a Medicare-enrolled provider, Benn has provided services to 1,530 Medicare beneficiaries, totaling 3,945 services with total Medicare billing of $354,890. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Hematology & Oncology
  • Location Paterson, NJ
  • Active Since 11/20/2006
  • Last Updated 01/04/2024
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1841364965

Products in Payments

  • SYNDROS (Drug) $6,620
  • OXBRYTA (Drug) $3,070
  • SUBSYS (Drug) $1,309
  • Nerlynx (Drug) $1,129
  • KEYTRUDA (Biological) $887.49
  • SIR-Spheres Microspheres (Device) $782.83
  • OPDIVO (Biological) $691.36
  • LYNPARZA (Drug) $616.62
  • Lenvima (Drug) $458.28
  • Stivarga (Drug) $371.01
  • REBLOZYL (Biological) $333.37
  • KISQALI (Drug) $297.02
  • IMFINZI (Biological) $295.58
  • Enhertu (Drug) $253.05
  • TAGRISSO (Drug) $249.17
  • Nubeqa (Drug) $245.97
  • DARZALEX (Biological) $236.40
  • ELIQUIS (Drug) $218.70
  • NINLARO (Drug) $212.22
  • PROMACTA (Drug) $210.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Paterson